SMAD2 and chronic kidney disease: Smad2 and Smad3 are mediators of extracellular matrix (ECM) production and activation of myofibroblasts via TGF-β1 [42] by binding to the promoter of collagens and inducing its production in CKD models and α-SMA induction in proximal-tubule epithelial human cells [43].